Ad is loading...
BEAM
Price
$25.05
Change
+$1.47 (+6.23%)
Updated
Nov 22 closing price
99 days until earnings call
OABI
Price
$3.92
Change
+$0.07 (+1.82%)
Updated
Nov 22 closing price
Ad is loading...

BEAM vs OABI

Header iconBEAM vs OABI Comparison
Open Charts BEAM vs OABIBanner chart's image
Beam Therapeutics
Price$25.05
Change+$1.47 (+6.23%)
Volume$1.19M
CapitalizationN/A
OmniAb
Price$3.92
Change+$0.07 (+1.82%)
Volume$247.69K
CapitalizationN/A
BEAM vs OABI Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BEAM vs. OABI commentary
Nov 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and OABI is a Buy.

COMPARISON
Comparison
Nov 25, 2024
Stock price -- (BEAM: $25.05 vs. OABI: $3.92)
Brand notoriety: BEAM and OABI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 109% vs. OABI: 63%
Market capitalization -- BEAM: $2.07B vs. OABI: $474.37M
BEAM [@Biotechnology] is valued at $2.07B. OABI’s [@Biotechnology] market capitalization is $474.37M. The market cap for tickers in the [@Biotechnology] industry ranges from $468.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileOABI’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • OABI’s FA Score: 1 green, 4 red.
According to our system of comparison, BEAM is a better buy in the long-term than OABI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while OABI’s TA Score has 2 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • OABI’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than OABI.

Price Growth

BEAM (@Biotechnology) experienced а +4.16% price change this week, while OABI (@Biotechnology) price change was +1.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.38%. For the same industry, the average monthly price growth was -4.87%, and the average quarterly price growth was +4.35%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

OABI is expected to report earnings on May 11, 2023.

Industries' Descriptions

@Biotechnology (+2.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.07B) has a higher market cap than OABI($474M). BEAM YTD gains are higher at: -7.972 vs. OABI (-36.467). OABI has higher annual earnings (EBITDA): -58.92M vs. BEAM (-160.83M). BEAM has more cash in the bank: 926M vs. OABI (59.4M). OABI has less debt than BEAM: OABI (23.8M) vs BEAM (162M). BEAM has higher revenues than OABI: BEAM (350M) vs OABI (20.4M).
BEAMOABIBEAM / OABI
Capitalization2.07B474M438%
EBITDA-160.83M-58.92M273%
Gain YTD-7.972-36.46722%
P/E RatioN/AN/A-
Revenue350M20.4M1,716%
Total Cash926M59.4M1,559%
Total Debt162M23.8M681%
TECHNICAL ANALYSIS
Technical Analysis
BEAMOABI
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
48%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
55%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
62%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
44%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 5 days ago
65%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
50%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VYSGX17.660.30
+1.73%
Voya Small Company W
CRSSX10.940.18
+1.67%
Catholic Rspnsbl Invstmnts Small-Cap Ins
WMCVX12.480.17
+1.38%
Wasatch Small Cap Value
EFCAX21.320.04
+0.19%
Emerald Insights A
LGLQX45.76-0.05
-0.11%
Lord Abbett Growth Leaders R2

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with NTLA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
+1.82%
NTLA - OABI
45%
Loosely correlated
+3.62%
ABCL - OABI
44%
Loosely correlated
+1.47%
AURA - OABI
44%
Loosely correlated
-0.89%
BEAM - OABI
43%
Loosely correlated
+6.23%
DNLI - OABI
43%
Loosely correlated
+1.94%
More